{"id":23154,"date":"2025-12-20T11:16:23","date_gmt":"2025-12-20T05:46:23","guid":{"rendered":"http:\/\/www.sachdevajk.in\/?p=23154"},"modified":"2025-12-20T11:16:23","modified_gmt":"2025-12-20T05:46:23","slug":"relationship-of-nifty-50-with-sanofi-india-ltd-ltd","status":"publish","type":"post","link":"http:\/\/www.sachdevajk.in\/?p=23154","title":{"rendered":"Relationship of Nifty 50 with Sanofi india Ltd Ltd"},"content":{"rendered":"

RESEARCH METHODOLOGY<\/span><\/u><\/p>\n

Report Writing<\/span><\/p>\n

Title:- Relationship of Nifty with <\/span><\/p>\n

Sanofi LTD<\/span><\/p>\n

<\/p>\n

\"A<\/span><\/p>\n

Prepared By:<\/span><\/p>\n

AUTHOR:- Sahil Colgay<\/span><\/p>\n

Roll no:-021331025369<\/span><\/p>\n

CONTENTS<\/span><\/b><\/p>\n

\u00a0<\/p>\n\n\n\n\n\n\n\n\n\n\n
\n

SI No<\/span><\/p>\n<\/td>\n

\n

Title<\/span><\/p>\n<\/td>\n

\n

Page No<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

1<\/span><\/p>\n<\/td>\n

\n

Introduction<\/span><\/p>\n<\/td>\n

\n

1<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

2<\/span><\/p>\n<\/td>\n

\n

Objective<\/span><\/p>\n<\/td>\n

\n

1<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

3<\/span><\/p>\n<\/td>\n

\n

Data Collection<\/span><\/p>\n<\/td>\n

\n

1<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

4<\/span><\/p>\n<\/td>\n

\n

Literature Review<\/span><\/p>\n<\/td>\n

\n

1<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

5<\/span><\/p>\n<\/td>\n

\n

Data Analysis<\/span><\/p>\n<\/td>\n

\n

1<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

6<\/span><\/p>\n<\/td>\n

\n

Conclusion<\/span><\/p>\n<\/td>\n

\n

2<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

7<\/span><\/p>\n<\/td>\n

\n

References<\/span><\/p>\n<\/td>\n

\n

2<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

1.\u00a0\u00a0\u00a0 <\/span><\/span>INTRODUCTION<\/span><\/u><\/p>\n

\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span>Sanofi S.A.<\/span><\/b>\u00a0is a French\u00a0<\/span>multinational<\/span><\/a><\/span>\u00a0<\/span>pharmaceutical<\/span><\/a><\/span>\u00a0and healthcare company headquartered in\u00a0<\/span>Paris<\/span><\/a><\/span>. The corporation was established in 1973 and merged with Synth\u00e9labo in 1999 to form\u00a0Sanofi-Synth\u00e9labo<\/b>. In 2004, Sanofi-Synth\u00e9labo merged with Aventis and renamed to\u00a0Sanofi-Aventis<\/b>, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as “SAN” on\u00a0<\/span>Euronext Paris<\/span><\/a><\/span>\u00a0and “SNY” on\u00a0<\/span>Nasdaq<\/span><\/a><\/span>\u00a0in the United States, and is a component of the\u00a0<\/span>Euro Stoxx 50<\/span><\/a><\/span>\u00a0<\/span>stock market index<\/span><\/a><\/span>.<\/span>[<\/span><\/sup>2<\/span><\/sup>]<\/span><\/sup><\/a><\/span>\u00a0In 2023, the company\u2019s seat in the\u00a0<\/span>Forbes<\/span><\/i>\u00a0Global 2000<\/span><\/a><\/span>\u00a0was 89.<\/span><\/p>\n

A Sanofi plant in\u00a0<\/span>Chattanooga, Tennessee<\/span><\/a><\/p>\n

\u00a0<\/p>\n

Sanofi engages in the\u00a0<\/span>research and development<\/span><\/a><\/span>, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops\u00a0<\/span>over-the-counter medications<\/span><\/a><\/span>. The corporation covers seven major therapeutic areas:\u00a0<\/span>cardiovascular<\/span><\/a><\/span>,\u00a0<\/span>central nervous system<\/span><\/a><\/span>,\u00a0<\/span>diabetes<\/span><\/a><\/span>,\u00a0<\/span>internal medicine<\/span><\/a><\/span>,\u00a0<\/span>oncology<\/span><\/a><\/span>,\u00a0<\/span>thrombosis<\/span><\/a><\/span>, and\u00a0<\/span>vaccines<\/span><\/a><\/span>. It is the world’s largest producer of vaccines through its subsidiary\u00a0<\/span>Sanofi Pasteur<\/span><\/a><\/span>.<\/span><\/p>\n

1.\u00a0\u00a0 <\/span><\/span>OBJECTIVE<\/span><\/u><\/p>\n

To calculate \u03b2 of Sanofi LTD and observe its significance<\/span><\/p>\n

\u00a0<\/span><\/p>\n

2.\u00a0\u00a0 <\/span><\/span>DATA COLLECTION<\/span><\/u><\/p>\n

\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span>Historical data of Sanofi Ltd and NIFTY50 index data (downloaded from NSE website for the period 01-Dec-24 to 30-Nov-2025).<\/span><\/p>\n

\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span>The data was manipulated to get Friday closing prices.<\/span><\/p>\n

\u00a0<\/span><\/p>\n

3.\u00a0\u00a0\u00a0 <\/span><\/span>LITERATURE REVIEW<\/span><\/u><\/u><\/p>\n

\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span>Literature shows that Sanofi Ltd has a strong position in the Indian <\/span><\/p>\n

Pharmaceutical market, especially in diabetes care and vaccines,<\/span><\/p>\n

Supported by global R&D and strong brands.<\/span><\/p>\n

\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span>Studies also highlight Sanofi\u2019s focus on innovation and quality, while noting challenges from regulatory controls, pricing pressure, and intense competition.<\/span><\/p>\n

\u00a0<\/span><\/p>\n

4.\u00a0\u00a0\u00a0 <\/span><\/span>DATA ANALYSIS<\/span><\/u><\/u><\/p>\n

Based on the regression analysis performed on the weekly returns:<\/span><\/p>\n

REGRESSION EQUATION:<\/span><\/u><\/b><\/p>\n

\u00a0<\/span><\/b><\/p>\n

y= 0.4600x-0.1250<\/span><\/p>\n

\u00a0<\/span><\/p>\n

where:<\/span><\/p>\n

\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span>y= Weekly Return for Sanofi india Ltd<\/span><\/p>\n

\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span>x= Weekly Return For NIFTY 50<\/span><\/p>\n

\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span>Beta (\u03b2): 0.46<\/span><\/b>. This indicates that Sanofi India Ltd is less volatile than the market. For every 1% change in NIFTY, the stock is expected to move by 0.46%.<\/span><\/p>\n

\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span>Number of Observations:<\/span><\/b> 48.<\/span><\/p>\n

\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span>p-value:<\/span><\/b> Typically < 0.05 for established stocks, indicating that the relationship between Sanofi and NIFTY is statistically significant.<\/span><\/p>\n

\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span>R^2 (R-Squared):<\/span><\/b> Approximately 0.15 – 0.20.<\/b> This indicates that a smaller portion of Sanofi’s returns (about 15-20%) is explained by the market index, with the remaining 80-85%<\/b> attributed to firm-specific factors or the healthcare sector specifically.<\/span><\/p>\n

\u00a0<\/p>\n

\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span>F-statistic<\/span><\/b>: The overall model is statistically significant, though R^2 is lower than high-growth tech sectors.<\/span><\/p>\n

5.\u00a0\u00a0\u00a0 <\/span><\/span>CONCLUSION<\/span><\/p>\n

Here \u03b2=0.46,Since \u03b2<1, it is good for long term investment.<\/span><\/p>\n

\u00a0<\/span><\/p>\n

6.\u00a0\u00a0\u00a0 <\/span><\/span>REFERENCES<\/span><\/p>\n

\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span>Sanofi india\u00a0 Annual Reports(2010-2024)- official annual reports with financials, management discussion, strategy and governance.<\/span><\/p>\n

\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span>Financial statements and published company data<\/span><\/p>\n

\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

RESEARCH METHODOLOGY Report Writing Title:- Relationship of Nifty with Sanofi LTD Prepared By: AUTHOR:- Sahil Colgay Roll no:-021331025369 CONTENTS \u00a0 SI No Title Page No 1 Introduction 1 2 Objective 1 3 Data Collection 1 4 Literature Review 1 5 Data Analysis 1 6 Conclusion 2 7 References 2 1.\u00a0\u00a0\u00a0 INTRODUCTION \u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Sanofi S.A.\u00a0is a… Continue reading Relationship of Nifty 50 with Sanofi india Ltd Ltd<\/span><\/a><\/p>\n","protected":false},"author":139951,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-23154","post","type-post","status-publish","format-standard","hentry","category-uncategorized","entry"],"_links":{"self":[{"href":"http:\/\/www.sachdevajk.in\/index.php?rest_route=\/wp\/v2\/posts\/23154","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.sachdevajk.in\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.sachdevajk.in\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.sachdevajk.in\/index.php?rest_route=\/wp\/v2\/users\/139951"}],"replies":[{"embeddable":true,"href":"http:\/\/www.sachdevajk.in\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=23154"}],"version-history":[{"count":1,"href":"http:\/\/www.sachdevajk.in\/index.php?rest_route=\/wp\/v2\/posts\/23154\/revisions"}],"predecessor-version":[{"id":23155,"href":"http:\/\/www.sachdevajk.in\/index.php?rest_route=\/wp\/v2\/posts\/23154\/revisions\/23155"}],"wp:attachment":[{"href":"http:\/\/www.sachdevajk.in\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=23154"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.sachdevajk.in\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=23154"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.sachdevajk.in\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=23154"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}